Evaluation of confirmatory data following the Article 12 MRL review for flutolanil.
MRL
confirmatory data
consumer risk assessment
flutolanil
pesticide
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
entrez:
7
7
2020
pubmed:
4
2
2019
medline:
4
2
2019
Statut:
epublish
Résumé
The applicant Nihon Nohyaku Co. Ltd. submitted a request to the competent national authority in Finland to evaluate the confirmatory data that were identified for flutolanil in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. The data gaps related to new residue trials for globe artichokes and beans with pods and for storage stability data in products of animal origin were addressed. Further risk management consideration is required regarding the tentative MRL on peppers and on certain products of animal origin, since the data gaps identified in the MRL review were not addressed or only partially addressed. A new metabolism study on ruminants was provided which will be assessed in the framework of the renewal of the active substance flutolanil; formally, this data gap is considered to be addressed. EFSA updated the most recent consumer risk assessment for flutolanil and concluded that the long-term dietary intake is unlikely to present a risk to consumer health. The conclusion reported in this reasoned opinion may need to be reconsidered in light of the outcome of the EU pesticides peer review.
Identifiants
pubmed: 32626220
doi: 10.2903/j.efsa.2019.5593
pii: EFS25593
pmc: PMC7009047
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e05593Informations de copyright
© 2019 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Références
EFSA J. 2017 Jul 25;15(7):e04929
pubmed: 32625585
EFSA J. 2019 Feb 04;17(2):e05593
pubmed: 32626220
EFSA J. 2008 Jul 28;6(7):126r
pubmed: 37213853